BMC’s Yawkey building doors are now closed as an entrance as part of our ongoing efforts to enhance our campus and provide you with the best clinical care.

All patients and visitors on our main campus must enter our hospital via Shapiro, Menino, or Moakley buildings, where they will be greeted by team members at a new centralized check-in desk before continuing to the hospital. We are excited to welcome you and appreciate your patience as we improve our facilities.


Vishakha Sabharwal, MD is a Boston Medical Center (BMC) pediatrician specializing in infectious diseases, travel health, management and treatment of TB in children and adolescents, management of children with Hepatitis C, and the medical needs of refugee and immigrant families. She is also an inpatient consultant on children with complex pediatric infectious diseases and also helps run the Pediatrics Infectious Diseases Fellowship program as an Associate Program Director. She is a co-investigator on an NIH R01 grant that studies how to prevent and treat Ear Infections and Ear Drainage and the prevention of biofilms after ear tube placement. Her research interests include perinatal infections especially viral infections like HCV and SARS–Cov2 transmission from mother to infant. Dr. Sabharwal has practiced at BMC for more than 15 years and currently is a Clinical Associate Professor of Pediatrics and a faculty member at Boston University’s Chobanian & Avedisian School of Medicine.

  • Administrative Title

    Clinical Associate Professor of Pediatrics | Chobanian & Avedisian School of Medicine at Boston University | Boston Medical Center Associate Program Director, Pediatrics Infectious Diseases Fellowship Program | Boston Medical Center

  • Education

    Government Medical College Patiala India, 1998
    Nassau University Medical Center, NY, 2004
    Boston University Medical Center, 2008
  • Board Certifications

    American Board of Pediatrics, Pediatrics Infectious Diseases
  • Research Interests

    Her research expertise is in the fields of Otitis media pathogenesis prevention and treatment, experimental otitis media modeling, development of novel methods of trans-tympanic delivery of antibiotics to treat otitis media, and treatment of biofilms on Tympanostomy tubes.